These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11688154)

  • 1. [Gene and immunotherapy of liver diseases].
    Cantz T; Ott M; Kubicka S; Manns MP
    Internist (Berl); 2001 Oct; 42(10):1357-62, 1364-5. PubMed ID: 11688154
    [No Abstract]   [Full Text] [Related]  

  • 2. Chapter of Gastroenterologists professional guidance for management of patients with liver disease in Singapore during the COVID-19 pandemic.
    Chang JPE; Wong YJ; Yang WL; Lim KBL; Tan PS; Ho GH; Yip BCH; Li JW; Chong CH; Ong DEH; Chua TS; Vu CKF; Gwee KA; Ang TL; Tan CK
    Singapore Med J; 2020 Dec; 61(12):619-623. PubMed ID: 32349198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F; Vangieri B; Cecere A; Gattoni A
    Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Toll-Like Receptor (TLR) 2 be considered as a new target for immunotherapy against hepatitis B infection?
    Bagheri V; Askari A; Arababadi MK; Kennedy D
    Hum Immunol; 2014 Jun; 75(6):549-54. PubMed ID: 24530748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The indications for orthotopic liver transplantation.
    MacDougall BR; Williams R
    Transplant Proc; 1979 Mar; 11(1):247-51. PubMed ID: 222017
    [No Abstract]   [Full Text] [Related]  

  • 6. Focusing on the past, present, and future of hepatology.
    Shouval D; Friedman SL
    J Hepatol; 2014 Dec; 61(6):1196-8. PubMed ID: 25195549
    [No Abstract]   [Full Text] [Related]  

  • 7. [The elder patient with advanced liver disease].
    Hopf U
    Praxis (Bern 1994); 2005 May; 94(18):743-50. PubMed ID: 15938386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatology 2010].
    Thimme R; Spangenberg HC; Blum HE
    Dtsch Med Wochenschr; 2010 Jun; 135(25-26):1290-4. PubMed ID: 20535665
    [No Abstract]   [Full Text] [Related]  

  • 9. Liver disease: current perspectives on medical and dental management.
    Golla K; Epstein JB; Cabay RJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Nov; 98(5):516-21. PubMed ID: 15529121
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review.
    Kanda T; Goto T; Hirotsu Y; Moriyama M; Omata M
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30889843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy.
    Sun C; Sun HY; Xiao WH; Zhang C; Tian ZG
    Acta Pharmacol Sin; 2015 Oct; 36(10):1191-9. PubMed ID: 26073325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and treatment of hepatitis C].
    Thies P; Schmid RM; Geisler F
    MMW Fortschr Med; 2012 Nov; 154(19):59-62. PubMed ID: 23173289
    [No Abstract]   [Full Text] [Related]  

  • 13. [Update hepatology in 2008].
    Zhang DF
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):1-4. PubMed ID: 19391278
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatology 2008].
    Thimme R; Spangenberg HC; Blum HE
    Dtsch Med Wochenschr; 2008 Jun; 133(25-26):1366-9. PubMed ID: 18553264
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of end-stage liver disease in chronic hepatitis B.
    Tan HH; Martin P
    Clin Liver Dis; 2010 Aug; 14(3):477-93. PubMed ID: 20638026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis C can be cured: will hepatitis B become next?].
    Chulanov VP; Zueva AP; Kostyushev DS; Brezgin SA; Volchkova EV; Maleyev VV
    Ter Arkh; 2017; 89(11):4-13. PubMed ID: 29260740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy for chronic hepatitis C: interferon and ribavirin.
    Christie JM; Chapman RW
    Hosp Med; 1999 May; 60(5):357-61. PubMed ID: 10396412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [24th Congress of the International Association of Hepatic Research].
    Pár A
    Orv Hetil; 2007 Jan; 148(4):190-1. PubMed ID: 17344138
    [No Abstract]   [Full Text] [Related]  

  • 19. [A report from the 12th Symposium on Viral Hepatitis and Liver Diseases].
    Wang GQ; Wei L; Weng XH; Zhuang H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Aug; 13(8):626-7. PubMed ID: 16093001
    [No Abstract]   [Full Text] [Related]  

  • 20. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
    Ando E; Kuromatsu R; Tanaka M; Takada A; Fukushima N; Sumie S; Nagaoka S; Akiyoshi J; Inoue K; Torimura T; Kumashiro R; Ueno T; Sata M
    J Clin Gastroenterol; 2006; 40(10):942-8. PubMed ID: 17063116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.